Home  |  Contact Us  |   Register for Updates  |   Site Map


Philip Ginsburg
Senior Medical Director

Dr. Ginsburg joined Prometheus Laboratories in May 2017. He has well over 20 years of commercial medical laboratory, diagnostics, and biotechnology industry experience. Dr. Ginsburg has overall responsibility for clinical strategy, and provides leadership and oversight for clinical operations and medical and scientific affairs.

Prior to joining Prometheus Laboratories, he had served as Chief Medical Officer for both publicly traded and privately held companies, including MDxHealth, Toma Biosciences, and Iris International, Inc.

Dr. Ginsburg was a founder of AlliedPath, a personalized medicine company with a state-of-the-art molecular diagnostics laboratory, which he sold to Iris International in July 2010, where he stayed on as Chief Medical Officer and Executive Vice President. He was concomitantly Chief Medical Officer and President of Arista, a diagnostics development and clinical laboratory division of Iris International.

In 2014, Iris was acquired by Beckman Coulter, a subsidiary of Danaher Corporation.

Before founding AlliedPath, Dr. Ginsburg was Senior Medical Director at Gen-Probe (now Hologic), and prior to that, served as a Medical Director at Quest Diagnostics.

Dr. Ginsburg earned his medical degree at the University of Pretoria School of Medicine, South Africa, later specializing in clinical pathology at the University of Witwatersrand and the South African Institute of Medical Research, with a subspecialty in microbiology and immunology.

Home  |  Contact Us  |  Site Map  |  Privacy Policy  |  Legal Notices  |  ProNet  |  Outside the US